Vaccitech PLC expected to post a loss of 55 cents a share - Earnings Preview

Barinthus Biotherapeutics

05/08/2023 03:12

* Vaccitech PLC  VACC.OQ   VACC.O  is expected to show a
fall in
quarterly revenue when it reports  results on August 7
(estimated). 
    * The Didcot Oxfordshire-based  company is expected to
report  a
96.5% decrease in revenue to $600 thousand from $17.06 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Vaccitech PLC is
for a
loss of 55 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vaccitech
PLC is
$15​, above​ its last closing price of $2.27. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.47       -0.50      -0.48     Beat    4.6
 Dec. 31 2023              -0.42      -0.57     Missed  -33.4
 Sep. 30 2022  -0.35       -0.33      0.22      Beat    166.7​
 Jun. 30 2022  -0.28       -0.32      0.41      Beat    226.8
 ​​Mar.        -0.29       -0.31      0.07      Beat    122.6
 31 2022                                                
 Dec. 31 2021  -0.22       -0.31      -0.38     Missed  -23.6​
 Sep. 30 2021  -0.42       -0.45      -0.13     Beat    71.3
 Jun. 30 2021  -0.61       -0.74      -0.64     Beat    13.5
 This summary was machine generated August 5 at 02:12 GMT.  All
figures in US dollars  unless otherwise stated